Jacques Banchereau
Director/Board Member at Ascend Biopharmaceuticals Ltd.
Profile
Jacques Banchereau is currently a Non-Executive Director at Ascend Biopharmaceuticals Ltd.
and a Director-Immunological Science Division at Jax Genomic Medicine.
He was previously the SVP, Head-Inflammation & Virology Discovery at Roche Ltd.
from 2010.
Prior to that, he worked as a Provisional Director at Neovacs SA.
Jacques Banchereau active positions
| Companies | Position | Start |
|---|---|---|
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Corporate Officer/Principal | 06/10/2010 |
| Jax Genomic Medicine | Corporate Officer/Principal | - |
Ascend Biopharmaceuticals Ltd.
 Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Former positions of Jacques Banchereau
| Companies | Position | End |
|---|---|---|
| NEOVACS | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEOVACS | Health Technology |
| Private companies | 3 |
|---|---|
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Finance |
Ascend Biopharmaceuticals Ltd.
Ascend Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ascend Biopharmaceuticals Ltd. is a cancer immunotherapy company that develops medicines to treat primary, recurrent, and metastatic cancers. It offers pipeline strategy that focuses on a number of oncology and dermato-oncology settings. The company was founded by Clement Leong on September 10, 2003 and is headquartered in Melbourne, Australia. | Health Technology |
| Jax Genomic Medicine |
- Stock Market
- Insiders
- Jacques Banchereau